Patients with psoriasis resistant to multiple biological therapies: characteristics and definition of a difficult-to-treat population

被引：19
作者：
Mastorino, Luca [1 ]
Roccuzzo, Gabriele [1 ]
Dapavo, Paolo [1 ]
Siliquini, Niccolo [1 ]
Avallone, Gianluca [1 ]
Rubatto, Marco [1 ]
Merli, Martina [1 ]
Agostini, Andrea [1 ]
Ribero, Simone [1 ]
Quaglino, Pietro [1 ]
机构：
[1] Univ Turin, Dermatol Clin, Dept Med Sci, Turin, Italy
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2022年 / 187卷 / 02期
关键词：
D O I：
10.1111/bjd.21048
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：263 / 265
页数：3
相关论文
共 8 条
  • [1] Azevedo A., 2018, DERMATOL ONLINE J, V24
  • [2] Effectiveness of anti-interleukin 23 biologic drugs in psoriasis patients who failed anti-interleukin 17 regimens. A real-life experience
    Bonifati, Claudio
    Morrone, Aldo
    Cristaudo, Antonio
    Graceffa, Dario
    [J]. DERMATOLOGIC THERAPY, 2021, 34 (01)
  • [3] Rapid and Sustained Improvement in a Patient With Plaque Psoriasis Switched to Brodalumab After Failing Treatment Clearance on Six Other Biologic Therapies
    Haycraft, Kathleen
    Cooke, Linda
    [J]. JOURNAL OF DRUGS IN DERMATOLOGY, 2020, 19 (01) : 86 - 88
  • [4] Predictive factors for switching in patients with psoriatic arthritis undergoing anti-TNFα, anti-IL12/23, or anti-IL17 drugs: a 15-year monocentric real-life study
    Lorenzin, Mariagrazia
    Ortolan, Augusta
    Cozzi, Giacomo
    Calligaro, Antonia
    Favaro, Maria
    Del Ross, Teresa
    Doria, Andrea
    Ramonda, Roberta
    [J]. CLINICAL RHEUMATOLOGY, 2021, 40 (11) : 4569 - 4580
  • [5] Secukinumab in multi-failure psoriatic patients: the last hope?
    Magnano, M.
    Loi, C.
    Patrizi, A.
    Sgubbi, P.
    Balestri, R.
    Rech, G.
    Tasin, L.
    Girardelli, C. R.
    Conti, A.
    Odorici, G.
    Campanati, A.
    Offidani, A. M.
    Bardazzi, F.
    [J]. JOURNAL OF DERMATOLOGICAL TREATMENT, 2018, 29 (06) : 583 - 585
  • [6] Efficacy and safety of risankizumab in psoriasis patients who failedanti-IL-17, anti-12/23 and/or antiIL-23: Preliminary data of a real-life 16-week retrospective study
    Megna, Matteo
    Fabbrocini, Gabriella
    Ruggiero, Angelo
    Cinelli, Eleonora
    [J]. DERMATOLOGIC THERAPY, 2020, 33 (06)
  • [7] EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris - Part 2: specific clinical and comorbid situations
    Nast, A.
    Smith, C.
    Spuls, P. I.
    Avila Valle, G.
    Bata-Csorgo, Z.
    Boonen, H.
    De Jong, E.
    Garcia-Doval, I.
    Gisondi, P.
    Kaur-Knudsen, D.
    Mahil, S.
    Malkonen, T.
    Maul, J. T.
    Mburu, S.
    Mrowietz, U.
    Reich, K.
    Remenyik, E.
    Ronholt, K. M.
    Sator, P. G.
    Schmitt-Egenolf, M.
    Sikora, M.
    Stromer, K.
    Sundnes, O.
    Trigos, D.
    Van der Kraaij, G.
    Yawalkar, N.
    Dressler, C.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2021, 35 (02) : 281 - 317
  • [8] Predictors of Response to Biologics in Patients with Moderate-to-severe Psoriasis: A Danish Nationwide Cohort Study
    Schwarz, Christopher Willy
    Loft, Nikolai
    Rasmussen, Mads Kirchheiner
    Nissen, Christoffer, V
    Dam, Tomas Norman
    Ajgeiy, Kawa Khaled
    Egeberg, Alexander
    Skov, Lone
    [J]. ACTA DERMATO-VENEREOLOGICA, 2021, 101
1